Top Markets
Coin of the day
BioPorto A/S BioPorto A/S

BioPorto A/S

BIOPOR
Rang in Aktien #21789
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aktienkurs
$0.20243542
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$100.22M
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-0.82%
Land
DK
Handel BioPorto A/S (BIOPOR)

Kategorie

Kursverlauf für BioPorto A/S (BIOPOR)
Höchster Schlusskurs: $0.19 am 2026-08-01

Niedrigster Schlusskurs: $2.98 am 2000-01-01
Kursverlauf der Aktie von BioPorto A/S von 2000 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 3.55%
2025 -25.78%
2024 -31.60%
2023 -2.40%
2022 -14.29%
2021 -27.93%
2020 28.04%
2019 -25.34%
2018 7.76%
2017 106.15%
2016 -57.88%
2015 108.23%
2014 14.34%
2013 -61.79%
2012 -29.98%
2011 -7.55%
2010 -0.68%
2009 38.84%
2008 8.07%
2007 32.59%
2006 -15.93%
2005 45.80%
2004 19.91%
2003 -42.43%
2002 -14.59%
2001 -27.23%
2000 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$628.91 25.78%
US
$219.26 3.52%
US
$23.60 79.96%
CN
$331.56 100.22%
US
$159.25 30.93%
US